Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 681885

Avoiding concomitant prescription of drugs with a potential for interaction : mission impossible?


Erdeljić, Viktorija; Francetić, Igor; Vlahović-Palčevski, Vera; Radošević, Nives; Makar-Ausperger, Ksenija; Likić, Robert
Avoiding concomitant prescription of drugs with a potential for interaction : mission impossible? // International journal of clinical pharmacology and therapeutics, 48 (2010), 12; 821-829 doi:10.5414/CPP48821 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 681885 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Avoiding concomitant prescription of drugs with a potential for interaction : mission impossible?

Autori
Erdeljić, Viktorija ; Francetić, Igor ; Vlahović-Palčevski, Vera ; Radošević, Nives ; Makar-Ausperger, Ksenija ; Likić, Robert

Izvornik
International journal of clinical pharmacology and therapeutics (0946-1965) 48 (2010), 12; 821-829

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
DDI

Sažetak
The increased prevalence of multi-drug therapy increases the risk of drug interactions. We conducted a study with the aim of evaluating the prevalence of prescribing potentially interacting drug combinations, their severity, mechanism, and in particular, their clinical relevance, in medical inpatients at two Croatian university hospitals. A cross-sectional study was conducted that included all medical inpatients receiving >= 2 drugs. Data were analyzed for 200 predefined drug-drug combinations compiled from the Micromedex data-base and literature. Two rating scales were used, one indicating the severity of a potential drug-drug interaction (pDDI) (minor, moderate, major), and the other assessing its clinical relevance (1: contraindicated ; 2: avoidable ; 3: consider risk-benefit ratio ; 4: hardly avoidable). The prescribing patterns were similar between evaluated hospitals. The prevalence of pDDIs was 46%. The mean number of drugs prescribed per patient was 6.2 (± 95% CI 5.9 – 6.5). Out of 200 predefined pDDIs, 96 were found in our study population with mean 2.8 pDDIs per patient (± 95% CI 2.4 – 3.1). Out of 478 single identified pDDIs, most were of moderate and major severity (56% and 33%, respectively). However, only 9% out of them were considered completely avoidable, 57% were considered hardly avoidable, and for 35% the consideration of risk-benefit ratio was recommended. Most pDDIs were classified as pharmacodynamic by mechanism of interaction (45%). Age and number of prescribed drugs were significant risk factors for prescription of potentially interacting drug combinations (OR 1.01 (± 95% CI 1.001 – 1.03) and OR 1.46 (± 95% CI 1.33 – 1.59), respectively). Despite the high prevalence of pDDIs, only 1 in 10 was considered avoidable.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Projekti:
062-0000000-3537 - Učinkovitost postupaka za promicanje racionalne uporabe antimikrobnih lijekova (Vlahović-Palčevski, Vera, MZOS ) ( CroRIS)

Ustanove:
Medicinski fakultet, Rijeka,
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb,
Klinički bolnički centar Rijeka

Poveznice na cjeloviti tekst rada:

doi www.dustri.com

Citiraj ovu publikaciju:

Erdeljić, Viktorija; Francetić, Igor; Vlahović-Palčevski, Vera; Radošević, Nives; Makar-Ausperger, Ksenija; Likić, Robert
Avoiding concomitant prescription of drugs with a potential for interaction : mission impossible? // International journal of clinical pharmacology and therapeutics, 48 (2010), 12; 821-829 doi:10.5414/CPP48821 (međunarodna recenzija, članak, znanstveni)
Erdeljić, V., Francetić, I., Vlahović-Palčevski, V., Radošević, N., Makar-Ausperger, K. & Likić, R. (2010) Avoiding concomitant prescription of drugs with a potential for interaction : mission impossible?. International journal of clinical pharmacology and therapeutics, 48 (12), 821-829 doi:10.5414/CPP48821.
@article{article, author = {Erdelji\'{c}, Viktorija and Franceti\'{c}, Igor and Vlahovi\'{c}-Pal\v{c}evski, Vera and Rado\v{s}evi\'{c}, Nives and Makar-Ausperger, Ksenija and Liki\'{c}, Robert}, year = {2010}, pages = {821-829}, DOI = {10.5414/CPP48821}, keywords = {DDI}, journal = {International journal of clinical pharmacology and therapeutics}, doi = {10.5414/CPP48821}, volume = {48}, number = {12}, issn = {0946-1965}, title = {Avoiding concomitant prescription of drugs with a potential for interaction : mission impossible?}, keyword = {DDI} }
@article{article, author = {Erdelji\'{c}, Viktorija and Franceti\'{c}, Igor and Vlahovi\'{c}-Pal\v{c}evski, Vera and Rado\v{s}evi\'{c}, Nives and Makar-Ausperger, Ksenija and Liki\'{c}, Robert}, year = {2010}, pages = {821-829}, DOI = {10.5414/CPP48821}, keywords = {DDI}, journal = {International journal of clinical pharmacology and therapeutics}, doi = {10.5414/CPP48821}, volume = {48}, number = {12}, issn = {0946-1965}, title = {Avoiding concomitant prescription of drugs with a potential for interaction : mission impossible?}, keyword = {DDI} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font